Applications

1763 – Amendment of MBS Item 11512 to include the use of portable home spirometry via telehealth

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status -
  • Type New application
  • Pre-PASC consultation Closed
  • Pre-MSAC consultation Not yet started
  • Outcome Pending

Application details

Reason for application

Amendment to MBS item.

Service or technology in this application

Portable home spirometry via telehealth is a spirometry service that will involve the patient performing their pulmonary function test at home with a qualified scientist from a respiratory lab in continuous attendance via telehealth.

Type: Investigative technology

Medical condition this application addresses

Spirometry is an essential tool for managing a range of obstructive and restrictive lung diseases. Obstructive lung disease includes but is not limited to the following; chronic obstructive pulmonary disease (COPD), bronchiectasis, asthma, emphysema, and bronchiolitis. Restrictive lung disease is a heterogeneous set of lung disorders that can be divided into intrinsic and extrinsic causes. Intrinsic causes are related to inflammatory processes within the lung, and extrinsic causes may be related to conditions impacting the chest wall.

Consultation survey and deadlines

  • PASC consultation: Closed 3 November 2023
  • MSAC consultation: MSAC consultation TBA – please subscribe to the MSAC bulletin to be notified when consultation opens for this application

Meetings to consider this application

  • PASC meeting: 7–8 December 2023
  • ESC meeting: -
  • MSAC meeting: -